We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




US Laboratories Surveyed for Malaria Diagnosis

By LabMedica International staff writers
Posted on 06 Jan 2011
The accuracy of laboratories in detecting and identifying malaria parasites and assessing malaria screening practices has been evaluated.

The American Proficiency Institute (API; Traverse City, MI, USA) has examined the diagnostic precision of laboratories in the US to identify different species of malaria parasites and assessed whether the correct follow-up procedures were practiced. More...


Malaria is usually diagnosed in the laboratory by microscopic examination of a stained thick and thin blood smear or by the use of a rapid diagnostic test (RDT). Malaria RDTs detect specific antigens (proteins) produced by malaria parasites, that are present in the blood of infected or recently infected individuals. Some RDTs can detect only one species of the malaria parasite, Plasmodium falciparum, while some also detect other species of the parasite, P. vivax, P. malariae and P. ovale. Blood for these tests are commonly obtained from a finger-prick.

API reviewed proficiency-testing data from 1999 to 2008 to determine the rates of unacceptable responses for detecting and identifying Plasmodium species, the parasites that cause malaria. Laboratories in the United States were better able to detect and identify P. falciparum than other types of parasite species. However, when assessing malaria screening practices among current proficiency testing providers, the review found that half of the surveyed laboratories failed to offer a complete diagnostic workup, 25.0% failed to screen both thick and thin slides, and 36.1% failed to issue a final report within 24 hours.

The US Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA) estimates that approximately 1,500 cases of imported malaria are diagnosed each year in the US. Of these, 71% were acquired in Africa and about 41% were due to P. falciparum. In December 2010, an autochthonous case of P. falciparum malaria was diagnosed in a 31-year-old female resident of Jacksonville (FL, USA) who had no history of international travel.

Daniel C. Edson, M.S., M.T. (ASCP), API president and lead author of the report, said, "Malaria is a serious, sometimes fatal, disease and laboratories should be better prepared to identify various species of malaria parasites, the more rapidly patients may be treated and hopefully cured". The study was published in December 2010, in Lab Medicine.

Related Links:

American Proficiency Institute
CDC




Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Automated Biochemical Analyzer
iBC 900
New
Staining Management Software
DakoLink
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The Volition Nu.Q nucleosome assay runs on the IDS i10 automated analyzer platform (Photo courtesy of VolitionRx)

Groundbreaking Lateral Flow Test Quantifies Nucleosomes in Whole Venous Blood in Minutes

Diagnosing immune disruptions quickly and accurately is crucial in conditions such as sepsis, where timely intervention is critical for patient survival. Traditional testing methods can be slow, expensive,... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.